Kevin represents his clients in all aspects of patent law, including due diligence investigations for mergers and acquisitions, patent counseling and prosecution, strategic management of patent portfolios and litigation, and opinion preparation, focusing his practice primarily on the biotechnological, pharmaceutical, and medical device industries.
Kevin’s work has encompassed a broad spectrum of technologies, including cellular therapies such as stem cells and CAR T-cells, biologics such as therapeutic antibodies and peptides, small molecules, and nucleic acids such as silencing RNAs and their use in treating conditions such as autoimmune diseases, pain, cancer and neurological diseases; nutraceuticals; gene editing; molecular biology for next generation sequencing; temperature management devices; coronary stent systems; hematology analyzers and controls; and diabetes management devices.
Clients value Kevin’s sophisticated business and communication skills that he puts into play to effectively advise them on the practical implications of their legal strategies. Kevin has assisted clients with multimillion-dollar acquisitions and collaborations, including due diligence and agreement drafting with various intellectual property, antitrust and corporate issues.
Kevin received his Ph.D. in Neuroscience from the University of Colorado. His studies focused on interactions between the central nervous system and the immune system, with emphasis on the role of immune cell products, particularly cytokines, in central nervous system function. Kevin is author of 21 peer-reviewed journal articles on cytokine effects in the central nervous system, cytokine gene expression, and viral mediated gene therapy. He has presented his work at various national and international scientific meetings.
After finishing his graduate work, Kevin joined the Molecular and Cellular Pathobiology Program at Children’s Memorial Research Center in Chicago to study the pathophysiology of a pediatric inflammatory disease. As an undergraduate at Creighton University, he was awarded a fellowship to study pharmacological and environmental regulation of serotonin receptors in the brain. His laboratory work involved utilization of various molecular biology techniques, immunoassays, and in vitro cell culture techniques.
Kevin has been listed as a Rising Star in the 2016–2017 editions of Illinois Super Lawyers. In 2016 the Law Bulletin Publishing Company chose him as one of the “40 Illinois Attorneys Under 40 to Watch.” Kevin has donated his time and energy to advocacy for blood cancer research and has served on the Leadership Board of the Illinois Chapter of the Leukemia & Lymphoma Society.